Kodiak Sciences Inc. , today reported business highlights and financial results for the quarter ended September 30, 2024. "In the third quarter we hosted an Investor R&D Day in New York," said Victor ...

EyePoint Pharmaceuticals' lead product, EYP-1901, shows promising phase 2 results for wet AMD and DME. Read more about EYPT ...

Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.

During the loading segment, subjects who have 20/80 vision or better and who satisfy other enrollment criteria receive two ...

Dr Menon believes that lifestyle modifications are “essential in managing diabetes and preventing complications.” His ...

Dossiers are also under review in multiple countries globally. About AVT06/AVT29 AVT06/AVT29 is a recombinant fusion protein and a biosimilar candidate to Eylea® (aflibercept) 2 mg and 8 mg dose, ...

The "Retinal Vein Occlusion Treatment Market by Treatment Type (Anti-VEGF Injection, Corticosteroid Treatment, Laser Therapy), Age Group (40-60, Above 60, Below 40), Condition Type, End User - Global ...

Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...